Is Hyperfine Inc (HYPR) overvalued? · rev $12.9M
Hyperfine Inc (HYPR) is a medical devices company listed on NASDAQ.
This page asks whether Hyperfine Inc (HYPR) looks expensive on cached numbers — not a short thesis.
Latest reported HYPR revenue for 2024-12-31 was $12.9M. Net income was -$40.7M. Revenue was up 16.8% from 2023-12-31 to 2024-12-31. HYPR currently screens at market cap $141.5M.
HYPR currently screens at market cap $141.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HYPR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HYPR stock page for the full model, not this heading.
Not investment advice.